Enanta Pharmaceuticals Stock Forecast

Buy or Hold candidate since Oct 01, 2025 Gain 20.83%

The Enanta Pharmaceuticals stock price gained 6.30% on the last trading day (Monday, 17th Nov 2025), rising from $12.06 to $12.82. During the last trading day the stock fluctuated 9.20% from a day low at $11.85 to a day high of $12.94. The price has risen in 6 of the last 10 days and is up by 18.48% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 129 thousand more shares were traded than the day before. In total, 400 thousand shares were bought and sold for approximately $5.12 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 30.23% during the next 3 months and, with a 90% probability hold a price between $12.54 and $22.61 at the end of this 3-month period.

ENTA Signals & Forecast

The Enanta Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $11.87 and $11.13. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, September 29, 2025, and so far it has fallen -15.44%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Enanta Pharmaceuticals stock

On the downside, the stock finds support just below today's level from accumulated volume at $11.97 and $10.61. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Enanta Pharmaceuticals finds support just below today's level at $11.97. If this is broken, then the next support from accumulated volume will be at $10.61 and $10.33.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.09 between high and low, or 9.20%. For the last week, the stock has had daily average volatility of 7.36%.

Our recommended stop-loss: $12.14 (-5.34%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 83 and this increases the risk substantially. There is a sell signal from a pivot top found 35 days ago.)

Trading Expectations (ENTA) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Enanta Pharmaceuticals to open at $12.54, and during the day (based on 14 day Average True Range), to move between $12.44 and $13.20, which gives a possible trading interval of +/-$0.765 (+/-6.15%) up or down from last closing price. If Enanta Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 6.15% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $11.97 (6.63%) than the resistance at $15.16 (18.25%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Enanta Pharmaceuticals stock A Buy?

Enanta Pharmaceuticals holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 6.131 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $12.54 ( 2.21%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk